FibroGen (FGEN) said Monday that David DeLucia has been named chief financial officer, effective immediately.

DeLucia succeeds Juan Graham, who stepped down on Sunday, the company said.

DeLucia most recently served as FibroGen's head of corporate financial planning and analysis, investor relations and treasury, the company said.